Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CHEN, Dung-Tsa")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 19 of 19

  • Page / 1
Export

Selection :

  • and

Effects of source water location, season, and nanofilter type on permeate water qualityCHELLAM, Shankararaman; CHEN, Dung-Tsa; FRANCIS, David J et al.Environmental engineering science. 2001, Vol 18, Num 4, pp 249-258, issn 1092-8758Article

Probe rank approaches for gene selection in oligonucleotide arrays with a small number of replicatesCHEN, Dung-Tsa; CHEN, James J; SOONG, Seng-Jaw et al.Bioinformatics (Oxford. Print). 2005, Vol 21, Num 12, pp 2861-2866, issn 1367-4803, 6 p.Article

Gene selection for oligonucleotide array: an approach using PM probe level data dataCHEN, Dung-Tsa; LIN, Sue-Hwa; SOONG, Seng-Jaw et al.Bioinformatics (Oxford. Print). 2004, Vol 20, Num 6, pp 855-862, issn 1367-4803, 8 p.Article

Evaluation of malignancy-risk gene signature in breast cancer patientsCHEN, Dung-Tsa; NASIR, Aejaz; VENKATARAMU, Chinnambally et al.Breast cancer research and treatment. 2010, Vol 120, Num 1, pp 25-34, issn 0167-6806, 10 p.Article

Sample size for gene expression microarray experimentsTSAI, Chen-An; WANG, Sue-Jane; CHEN, Dung-Tsa et al.Bioinformatics (Oxford. Print). 2005, Vol 21, Num 8, pp 1502-1508, issn 1367-4803, 7 p.Article

Vitamin E δ-Tocotrienol Prolongs Survival in the LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre (KPC) Transgenic Mouse Model of Pancreatic CancerHUSAIN, Kazim; CENTENO, Barbara A; CHEN, Dung-Tsa et al.Cancer prevention research (Philadelphia, Pa.). 2013, Vol 6, Num 10, pp 1074-1083, issn 1940-6207, 10 p.Article

Antitumor activity of the 16-kDa prolactin fragment in prostate cancerKIM, Jeri; WEIPING LUO; CHEN, Dung-Tsa et al.Cancer research (Baltimore). 2003, Vol 63, Num 2, pp 386-393, issn 0008-5472, 8 p.Article

Prognostic and Predictive Value of a Malignancy-Risk Gene Signature in Early-Stage Non-Small Cell Lung CancerCHEN, Dung-Tsa; HSU, Ying-Lin; FULP, William J et al.Journal of the National Cancer Institute. 2011, Vol 103, Num 24, pp 1859-1870, issn 0027-8874, 12 p.Article

A novel time-course cDNA microarray analysis method identifies genes associated with the development of cisplatin resistanceWHITESIDE, Martin A; CHEN, Dung-Tsa; DESMOND, Renee A et al.Oncogene (Basingstoke). 2004, Vol 23, Num 3, pp 744-752, issn 0950-9232, 9 p.Article

Laboratory tests to determine the cause of hypokalemia and paralysisLIN, Shih-Hua; LIN, Yuh-Feng; CHEN, Dung-Tsa et al.Archives of internal medicine (1960). 2004, Vol 164, Num 14, pp 1561-1566, issn 0003-9926, 6 p.Article

Effectiveness of multiple internal standards: Deuterated analogues of methylenedioxymethamphetamine, methylenedioxyamphetamine, methamphetamine, and amphetamineLIN, Dong-Liang; LIU, Hsiu-Chuan; YIN, Rea-Ming et al.Journal of analytical toxicology. 2004, Vol 28, Num 8, pp 650-654, issn 0146-4760, 5 p.Article

Detecting the expression of human endogenous retrovirus E Envelope transcripts in human prostate adenocarcinomaWANG-JOHANNING, Feng; FROST, Andra R; BIXI JIAN et al.Cancer. 2003, Vol 98, Num 1, pp 187-197, issn 0008-543X, 11 p.Article

Identification of a risk dependent microRNA expression signature in myelodysplastic syndromesSOKOL, Lubomir; CACERES, Gisela; MOSCINSKI, Lynn et al.British journal of haematology. 2011, Vol 153, Num 1, pp 24-32, issn 0007-1048, 9 p.Article

Treatment of refractory urothelial carcinoma with alternating paclitaxel, methotrexate, cisplatin (TMP) and 5-fluorouracil, α-interferon, cisplatin (FAP)TU, Shi-Ming; MILLIKAN, Randall E; PAGLIARO, Lance C et al.Urologic oncology. 2003, Vol 21, Num 5, pp 342-348, issn 1078-1439, 7 p.Article

BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient SurvivalMARCHION, Douglas C; COTTRILL, Hope M; HAKAM, Ardeshir et al.Clinical cancer research (Print). 2011, Vol 17, Num 19, pp 6356-6366, issn 1078-0432, 11 p.Article

Bortezomib salvage followed by a Phase I/II study of bortezomib plus high-dose melphalan and tandem autologous transplantation for patients with primary resistant myelomaNISHIHORI, Taiga; ALEKSHUN, Todd J; YARDE, Danielle N et al.British journal of haematology. 2012, Vol 157, Num 5, pp 553-563, issn 0007-1048, 11 p.Article

Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell culturesDIAS, João D; GUS, Kilian; PESONEN, Sari et al.European journal of cancer (1990). 2010, Vol 46, Num 3, pp 625-635, issn 0959-8049, 11 p.Article

Mre11 inhibition by oncolytic adenovirus associates with autophagy and underlies synergy with ionizing radiationRAJECKI, Maria; AF HÄLLSTRÖM, Taija; GUSE, Kilian et al.International journal of cancer (Print). 2009, Vol 125, Num 10, pp 2441-2449, issn 0020-7136, 9 p.Article

Efficacy of Platelet-Rich Plasma on Wound Healing in RabbitsLEE, Hung-Wen; REDDY, Michael S; GEURS, Nicolaas et al.Journal of periodontology. 2008, Vol 79, Num 4, pp 691-696, issn 0022-3492, 6 p.Article

  • Page / 1